Omron Healthcare

No. Omron Healthcare is a medical-device subsidiary of Omron Corporation, a Japanese industrial conglomerate publicly traded on the Tokyo Stock Exchange. It does not function as an allocator, family office, or investment vehicle — it manufactures and sells consumer health products.

The firm's core product is home-use blood pressure monitors, which it claims is the world's No. 1 brand with over 400 million units sold (per the firm's website, 2025). It also produces nebulizers, scales, and pain management devices. Many monitors are wireless and sync with the OMRON Connect app for data tracking and atrial fibrillation screening.

The US headquarters is in Lake Forest, Illinois (per the firm's website). Omron Healthcare operates as a subsidiary of Omron Corporation, which is headquartered in Kyoto, Japan.

No. Omron Healthcare does not manage outside investor capital. It is a product company funded by its parent, Omron Corporation. Disclosures for AUM, deployment, or team size are not applicable or not publicly available.

The firm competes in the home health monitoring market with brands like Withings, iHealth, and Qardio. In the broader medical device space, it also competes with Philips and GE Healthcare's consumer health divisions.

The firm states a commitment to 'Going for Zero' — a goal of eliminating heart attacks and strokes through technology and consumer education (per the firm's website, 2025). This is a marketing and product-development philosophy, not a philanthropic foundation with separate financials.

There is no public evidence that Omron Healthcare operates a corporate venture capital arm or makes independent investments. Its parent, Omron Corporation, has a venture unit (Omron Ventures), but that is a separate entity focused on industrial automation and sensing technologies, not consumer health.